GlassScriptPhysician profile
Alexander Canales
NPI 1699180984
$3,204.06
in general payments reported to CMS, 2019-2025
11 companies · $1,645 in 2025
The $1,645 reported for 2025 was more than what 77% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.64 · 2020: $1,136 · 2023: $20.00 · 2024: $385 · 2025: $1,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,059 · Food and Beverage: $971 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,058.91 |
| Food and Beverage | $971.20 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,437.25 | 2025 | |
| Acumed LLC | $1,136.31 | 2020 | |
| Integra Lifesciences Corporation | $177.74 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Aroa Biosurgery Incorporated | $151.96 | 2024 | |
| Csl Behring | $145.00 | 2023-2025 | Kcentra |
| Baxter Healthcare | $43.44 | 2025 | Tisseel |
| Ceribell, INC. | $37.02 | 2024 | Pocket Eeg Device |
| Mindray Ds USA, INC. | $22.39 | 2025 | Te X, Te7 Max |
| Smith+Nephew, INC. | $18.72 | 2024 | Renasys Go V2 Home |
| Acell, INC. | $17.64 | 2019 | |
| Teleflex LLC | $16.59 | 2025 | Quikclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Canales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.